Pharmacologic reduction of CNS noradrenergic activity in PTSD: The case for clonidine and prazosin

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

This article reviews the neurobiologic rationale for and presents clinical guidance concerning the use of medications that reduce central nervous system noradrenergic activity in the treatment of intrusive symptoms of posttraumatic stress disorder. The authors reviewed neurobiological studies, nonclinical studies using animal models, clinical case reports, open-label drug studies, and blinded, placebo-controlled drug studies. This review of the basic science and clinical literature, and the authors' clinical experience with culturally and demographically diverse populations, indicate that clonidine and prazosin can play a useful role in treating sleep disturbance and hyperarousal in posttraumatic stress disorder, with minimal adverse effects and low financial cost.

Original languageEnglish (US)
Pages (from-to)72-78
Number of pages7
JournalJournal of Psychiatric Practice
Volume13
Issue number2
DOIs
StatePublished - Mar 2007

Fingerprint

Prazosin
Clonidine
Post-Traumatic Stress Disorders
Pharmaceutical Preparations
Sleep
Central Nervous System
Animal Models
Placebos
Costs and Cost Analysis
Population
Therapeutics

Keywords

  • Clonidine
  • Hyperarousal
  • Nightmares
  • Noradrenergic reduction
  • Posttraumatic stress disorder
  • Prazosin
  • Psychopharmacology
  • Sleep disturbances

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{a22c69e0420e48db897ff2bf166e245d,
title = "Pharmacologic reduction of CNS noradrenergic activity in PTSD: The case for clonidine and prazosin",
abstract = "This article reviews the neurobiologic rationale for and presents clinical guidance concerning the use of medications that reduce central nervous system noradrenergic activity in the treatment of intrusive symptoms of posttraumatic stress disorder. The authors reviewed neurobiological studies, nonclinical studies using animal models, clinical case reports, open-label drug studies, and blinded, placebo-controlled drug studies. This review of the basic science and clinical literature, and the authors' clinical experience with culturally and demographically diverse populations, indicate that clonidine and prazosin can play a useful role in treating sleep disturbance and hyperarousal in posttraumatic stress disorder, with minimal adverse effects and low financial cost.",
keywords = "Clonidine, Hyperarousal, Nightmares, Noradrenergic reduction, Posttraumatic stress disorder, Prazosin, Psychopharmacology, Sleep disturbances",
author = "James Boehnlein and Kinzie, {John (Dave)}",
year = "2007",
month = "3",
doi = "10.1097/01.pra.0000265763.79753.c1",
language = "English (US)",
volume = "13",
pages = "72--78",
journal = "Journal of Psychiatric Practice",
issn = "1527-4160",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Pharmacologic reduction of CNS noradrenergic activity in PTSD

T2 - The case for clonidine and prazosin

AU - Boehnlein, James

AU - Kinzie, John (Dave)

PY - 2007/3

Y1 - 2007/3

N2 - This article reviews the neurobiologic rationale for and presents clinical guidance concerning the use of medications that reduce central nervous system noradrenergic activity in the treatment of intrusive symptoms of posttraumatic stress disorder. The authors reviewed neurobiological studies, nonclinical studies using animal models, clinical case reports, open-label drug studies, and blinded, placebo-controlled drug studies. This review of the basic science and clinical literature, and the authors' clinical experience with culturally and demographically diverse populations, indicate that clonidine and prazosin can play a useful role in treating sleep disturbance and hyperarousal in posttraumatic stress disorder, with minimal adverse effects and low financial cost.

AB - This article reviews the neurobiologic rationale for and presents clinical guidance concerning the use of medications that reduce central nervous system noradrenergic activity in the treatment of intrusive symptoms of posttraumatic stress disorder. The authors reviewed neurobiological studies, nonclinical studies using animal models, clinical case reports, open-label drug studies, and blinded, placebo-controlled drug studies. This review of the basic science and clinical literature, and the authors' clinical experience with culturally and demographically diverse populations, indicate that clonidine and prazosin can play a useful role in treating sleep disturbance and hyperarousal in posttraumatic stress disorder, with minimal adverse effects and low financial cost.

KW - Clonidine

KW - Hyperarousal

KW - Nightmares

KW - Noradrenergic reduction

KW - Posttraumatic stress disorder

KW - Prazosin

KW - Psychopharmacology

KW - Sleep disturbances

UR - http://www.scopus.com/inward/record.url?scp=34247156174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247156174&partnerID=8YFLogxK

U2 - 10.1097/01.pra.0000265763.79753.c1

DO - 10.1097/01.pra.0000265763.79753.c1

M3 - Article

C2 - 17414682

AN - SCOPUS:34247156174

VL - 13

SP - 72

EP - 78

JO - Journal of Psychiatric Practice

JF - Journal of Psychiatric Practice

SN - 1527-4160

IS - 2

ER -